Trial intelligence / Profile preview

Adsorbed Acellular DTP Combined Vaccine Phase III Trial in Chinese Infants

CTR20130164Phase 3Completed

Sponsor
Beijing Minhai Biological
Start
Apr 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed) in pertussis, diphtheria, Tetanus, sponsored by Beijing Minhai Biological. Started Apr 2014; status: completed.

02

Drugs

diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed)
03

Conditions

pertussisdiphtheriaTetanus

Beyond the preview

Go deeper on CTR20130164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call